"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
ETOPOSIDE - ORAL
COMMON BRAND NAME(S): Vepesid
WARNING: Severe lowering of blood counts (myelosuppression) may occur, which may cause infection or bleeding (sometimes fatal). Seek immediate medical attention if you develop symptoms of infection (fever, chills, persistent sore throat) or unusually easy bruising or bleeding (see also Side Effects section).
USES: Etoposide is used alone or in combination with other chemotherapies to treat certain forms of cancer (e.g., small cell lung cancer). Etoposide works by slowing cancer cell growth. It is also commonly known as VP-16.
OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.
This drug may also be used to treat certain types of leukemias, lymphomas, ovarian cancer, testicular cancer, and a certain type of prostate cancer.
HOW TO USE: Take this medication by mouth exactly as prescribed. The dosage is based on your medical condition and response to therapy.
Do not increase your dose or take this medication more often without your doctor's approval. Your condition will not improve any faster and the risk of serious side effects may be increased.
Avoid eating grapefruit or drinking grapefruit juice while being treated with this medication unless your doctor instructs you otherwise. Grapefruit juice can change the amount of certain medications in your bloodstream. Consult your doctor or pharmacist for more details.
Do not stop taking this medication, even if you feel nauseated or experience vomiting. If you vomit shortly after a dose or if you miss a dose, contact your doctor.
Since dust containing this drug may be inhaled, women who are pregnant or who may become pregnant should not handle or break the capsules of this medication.
Additional VePesid Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.